Use of long-acting injectable buprenorphine in the correctional setting

Original research
by
Martin, Rosemarie A. et al

Release Date

2022

Geography

USA

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

Few jails and prisons offer MOUD and most limit access. Extended-release buprenorphine (XR-BUP), a novel monthly injectable MOUD formulation, could be uniquely poised to address treatment access in correctional settings.

Findings/Key points

XR-BUP is feasible and acceptable in correctional settings. XR-BUP addresses administrative concerns of diversion that obstruct lifesaving MOUD and offers another safe and effective treatment option.

Design/methods

Retrospective cohort study (n=54)

Keywords

Justice system/law enforcement
Diversion
Substitution/OAT
Outcomes